FIELD: pharmaceutical industry and pulmonology. SUBSTANCE: isoniazid is added to concentration 0.4 to 4.0% to dextran (for example, rheopolyglukin) activated by irradiation of deceleration gamma-emission in dose 2.5-3.5 Mrad. Mixture is heated to 100 C, kept at this temperature for 10-15 min, and cooled to room temperature. EFFECT: simplified procedure. 3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING PROLONGED ACTION ISONIASIDE | 2000 |
|
RU2192865C2 |
| METHOD OF TREATMENT THE GENERAL TUBERCULOSIS PROCESS IN EXPERIMENT | 1993 |
|
RU2087146C1 |
| PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
| PHARMACEUTICAL COMPOSITION SHOWING PROLONGED ANTITUBERCULOSIS EFFECT | 1999 |
|
RU2169565C1 |
| ANTIBIOTIC CONJUGATE AND ANTIBACTERIAL MEDICINAL AGENT BASED ON SAID CONJUGATE | 2007 |
|
RU2371447C2 |
| METHOD FOR OXIDIZED DEXTRAN OBTAINING | 2016 |
|
RU2618341C1 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF PERIODONTIUM | 1999 |
|
RU2158581C2 |
| METHOD OF PREPARING NON-RADIOACTIVE LABELLED PROBE FOR DETERMINATION OF NUCLEOTIDE SERIES | 1992 |
|
RU2049821C1 |
| METHOD FOR PREPARING WATER-SOLUBLE IMMOBILIZED ENZYME PROTEASE PREPARATION | 2004 |
|
RU2270861C1 |
| METHOD OF DETERMINATION OF EMBRYO POTENTIAL DONORS AND EARLY PUBERTY IN SHEEP | 1992 |
|
RU2032338C1 |
